AstraZeneca

Pfizer raises its ‘final’ bid for AstraZeneca to £69bn

Pfizer CEO Ian Read on Sunday described the company's new proposal for AstraZeneca as "compelling" and cautioned that the American drugmaker would walk away if AstraZeneca didn't accept it.

Companies: 
General: 
People: 

Pfizer-AstraZeneca deal is not inevitable: Pascal Soriot

Pfizer's takeover bid for AstraZeneca is not inevitable and the Anglo-Swedish pharmaceutical giant can create value for its shareholder on its own, according to AstraZeneca CEO Pascal Soriot's claims.

Companies: 
General: 
People: 

AstraZeneca is apparently not British

Amid ongoing political storm over Pfizer's potential takeover of British pharmaceuticals giant AstraZeneca, some analysts have pointed out that AstraZeneca is apparently not British.

General: 
Companies: 

Two state leaders express concerns over Pfizer’s potential takeover of AstraZeneca

Governors of Delaware and Maryland have expressed their concerns over the impact of Pfizer Inc.'s proposed takeover of British pharmaceuticals giant AstraZeneca on workers as well as the states' economies.

Companies: 
General: 
Region: 

British lawmakers anxiously watching Pfizer-AstraZeneca talks

British lawmakers are concerned about the future of AstraZeneca and thousands of its employees, as U. S.-based pharmaceuticals giant Pfizer is preparing a £60 billion (nearly $100bn) takeover bid for the British firm.

Companies: 
General: 
People: 

Pages

Subscribe to RSS - AstraZeneca